January 2, 2024 · Form 4 insider transaction
Gano Kyle bought 68,884 shares of Neurocrine Biosciences, Inc. at $19.59 per share, a transaction worth $1.35M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.